Fibrin sealant spray - Takeda
Alternative Names: Artiss; Fibrin sealant (Human); Fibrin sealant - human; Slow-setting fibrin sealantLatest Information Update: 12 Jan 2022
At a glance
- Originator Baxter Healthcare Corporation
- Developer Takeda
- Class Antihaemorrhagics; Blood coagulation factors; Blood proteins; Serine endopeptidases
- Mechanism of Action Fibrinogen replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Burns
Most Recent Events
- 08 Jan 2019 Shire has been acquired and merged into Takeda
- 03 Jun 2016 Baxalta has been acquired and merged into Shire